Florian Märkl
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Chemokine receptors and signaling
Papers in ⓘ
- Oncology 8
- CAR-T cell therapy research 8
- Chemokine receptors and signaling 1
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Stefan Endres (4 shared papers)Sebastian Kobold (8 shared papers)Duc Huynh (2 shared papers)Pia Winter (2 shared papers)Daria Briukhovetska (1 shared paper)Tobias Feuchtinger (1 shared paper)Bruno L. Cadilha (1 shared paper)Mohamed-Reda Benmebarek (1 shared paper)
- Journals
- Cancer Immunology Immunotherapy (2 papers)Blood (2 papers)British Journal of Cancer (1 paper)Blood Advances (1 paper)Seminars in Immunopathology (1 paper)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Florian Märkl
7 papers receiving 137 citations
Peers
Comparison fields: 5 of 36
- Immunology 88
- Oncology 97
- Cancer Research 9
- Biotechnology 5
- Biomedical Engineering 22
Countries citing papers authored by Florian Märkl
This map shows the geographic impact of Florian Märkl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Märkl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Märkl more than expected).
Fields of papers citing papers by Florian Märkl
This network shows the impact of papers produced by Florian Märkl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Märkl. The network helps show where Florian Märkl may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Märkl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 110 | |
| 2 | 2022 | 12 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2025 | 0 |
About Florian Märkl
Florian Märkl is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Biomedical Engineering, having authored 8 papers that have together received 140 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Immunotherapy and Immune Responses (3 papers), CRISPR and Genetic Engineering (2 papers), Immune Cell Function and Interaction (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Chemokine receptors and signaling (1 paper), Nanowire Synthesis and Applications (1 paper) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Immunology (88 citations), Oncology (97 citations), Cancer Research (9 citations), Biotechnology (5 citations) and Biomedical Engineering (22 citations). Florian Märkl has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Stefan Endres, Sebastian Kobold, Duc Huynh, Pia Winter, Daria Briukhovetska, Tobias Feuchtinger, Bruno L. Cadilha, Mohamed-Reda Benmebarek, Ruth Grünmeier and Matthias Seifert. Their work appears in journals such as Cancer Immunology Immunotherapy, Blood, British Journal of Cancer, Blood Advances and Seminars in Immunopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.